HSA
Hussman Strategic Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-9,300
| Closed | -$422K | – | 243 |
|
|
2023
Q3 | $422K | Hold |
9,300
| – | – | 0.08% | 250 |
|
|
2023
Q2 | $522K | Sell |
9,300
-7,300
| -44% | -$410K | 0.1% | 248 |
|
|
2023
Q1 | $751K | Hold |
16,600
| – | – | 0.12% | 241 |
|
|
2022
Q4 | $675K | Buy |
16,600
+6,200
| +60% | +$252K | 0.11% | 239 |
|
|
2022
Q3 | $680K | Sell |
10,400
-10,400
| -50% | -$680K | 0.12% | 235 |
|
|
2022
Q2 | $1.26M | Buy |
20,800
+10,400
| +100% | +$632K | 0.22% | 168 |
|
|
2022
Q1 | $653K | Hold |
10,400
| – | – | 0.13% | 228 |
|
|
2021
Q4 | $788K | Sell |
10,400
-2,000
| -16% | -$152K | 0.17% | 190 |
|
|
2021
Q3 | $1.39M | Buy |
12,400
+3,100
| +33% | +$347K | 0.31% | 130 |
|
|
2021
Q2 | $1.51M | Buy |
9,300
+5,700
| +158% | +$923K | 0.31% | 128 |
|
|
2021
Q1 | $439K | Sell |
3,600
-6,600
| -65% | -$805K | 0.09% | 270 |
|
|
2020
Q4 | $1.56M | Sell |
10,200
-20,400
| -67% | -$3.12M | 0.41% | 97 |
|
|
2020
Q3 | $2.56M | Buy |
30,600
+15,250
| +99% | +$1.28M | 0.68% | 32 |
|
|
2020
Q2 | $1.13M | Hold |
15,350
| – | – | 0.29% | 138 |
|
|
2020
Q1 | $651K | Buy |
15,350
+5,100
| +50% | +$216K | 0.18% | 198 |
|
|
2019
Q4 | $624K | Buy |
+10,250
| New | +$624K | 0.2% | 160 |
|